Hyperprogressive disease during PD-1 blockade in patients with advanced pancreatic cancer
The occurrence of markedly accelerated tumor growth during immunotherapy is considered a new mode of progression called hyperprogressive disease (HPD) and its impact on pancreatic cancer (PC) patients receiving immunotherapy is unknown. In this study, we described and explored the incidence, prognos...
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Taylor & Francis Group
2023-08-01
|
| Schriftenreihe: | Human Vaccines & Immunotherapeutics |
| Schlagworte: | |
| Online-Zugang: | http://dx.doi.org/10.1080/21645515.2023.2252692 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|